Quest Pharmatech Stock Buy Hold or Sell Recommendation
| QPTFF Stock | USD 0.01 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Quest PharmaTech is 'Strong Sell'. Macroaxis provides Quest PharmaTech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding QPTFF positions.
Check out Quest PharmaTech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Quest and provide practical buy, sell, or hold advice based on investors' constraints. Quest PharmaTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
Quest |
Execute Quest PharmaTech Buy or Sell Advice
The Quest recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Quest PharmaTech. Macroaxis does not own or have any residual interests in Quest PharmaTech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Quest PharmaTech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Quest PharmaTech Trading Alerts and Improvement Suggestions
| Quest PharmaTech generated a negative expected return over the last 90 days | |
| Quest PharmaTech has some characteristics of a very speculative penny stock | |
| Quest PharmaTech has accumulated 1000 K in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Quest PharmaTech has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Quest PharmaTech until it has trouble settling it off, either with new capital or with free cash flow. So, Quest PharmaTech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Quest PharmaTech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Quest to invest in growth at high rates of return. When we think about Quest PharmaTech's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (85.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quest PharmaTech has accumulated about 518.76 K in cash with (170.78 K) of positive cash flow from operations. | |
| Roughly 17.0% of Quest PharmaTech outstanding shares are owned by corporate insiders |
Quest PharmaTech current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Quest analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Quest analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Quest PharmaTech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Quest PharmaTech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Quest PharmaTech's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Quest pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Quest PharmaTech Volatility Alert
At this time Quest PharmaTech exhibits very low volatility. Quest PharmaTech is a penny stock. Although Quest PharmaTech may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Quest PharmaTech. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Quest instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Quest PharmaTech Fundamentals Vs Peers
Comparing Quest PharmaTech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Quest PharmaTech's direct or indirect competition across all of the common fundamentals between Quest PharmaTech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Quest PharmaTech or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Quest PharmaTech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Quest PharmaTech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Quest PharmaTech to competition |
| Fundamentals | Quest PharmaTech | Peer Average |
| Return On Equity | -0.62 | -0.31 |
| Return On Asset | -0.0038 | -0.14 |
| Current Valuation | 7.81 M | 16.62 B |
| Shares Outstanding | 169.13 M | 571.82 M |
| Shares Owned By Insiders | 16.80 % | 10.09 % |
| Price To Earning | 0.14 X | 28.72 X |
| Price To Book | 0.19 X | 9.51 X |
| EBITDA | (84.99 M) | 3.9 B |
| Net Income | (85.04 M) | 570.98 M |
| Cash And Equivalents | 518.76 K | 2.7 B |
| Total Debt | 1000 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 0.52 X | 2.16 X |
| Book Value Per Share | 0.52 X | 1.93 K |
| Cash Flow From Operations | (170.78 K) | 971.22 M |
| Earnings Per Share | (0.39) X | 3.12 X |
| Number Of Employees | 11 | 18.84 K |
| Beta | 0.84 | -0.15 |
| Market Capitalization | 12.89 M | 19.03 B |
| Total Asset | 91.03 M | 29.47 B |
| Z Score | 7.2 | 8.72 |
| Net Asset | 91.03 M |
Quest PharmaTech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Quest . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0133 | |||
| Day Typical Price | 0.0133 |
About Quest PharmaTech Buy or Sell Advice
When is the right time to buy or sell Quest PharmaTech? Buying financial instruments such as Quest Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Quest PharmaTech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Quest Pink Sheet
Quest PharmaTech financial ratios help investors to determine whether Quest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Quest with respect to the benefits of owning Quest PharmaTech security.